179 related articles for article (PubMed ID: 34518053)
1. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
[TBL] [Abstract][Full Text] [Related]
2. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
3. Overall survival after pelvic exenteration for gynecologic malignancy.
Westin SN; Rallapalli V; Fellman B; Urbauer DL; Pal N; Frumovitz MM; Ramondetta LM; Bodurka DC; Ramirez PT; Soliman PT
Gynecol Oncol; 2014 Sep; 134(3):546-51. PubMed ID: 25014540
[TBL] [Abstract][Full Text] [Related]
4. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
6. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A
Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295
[TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration as ultimate ratio for gynecologic cancers: single-center analyses of 37 cases.
de Gregorio N; de Gregorio A; Ebner F; Friedl TWP; Huober J; Hefty R; Wittau M; Janni W; Widschwendter P
Arch Gynecol Obstet; 2019 Jul; 300(1):161-168. PubMed ID: 31011878
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
9. Influence of tumor size on outcomes following pelvic exenteration.
Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
[TBL] [Abstract][Full Text] [Related]
10. Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.
Moreno-Palacios E; Diestro MD; De Santiago J; Hernández A; Zapardiel I
Int J Gynecol Cancer; 2015 Jul; 25(6):1109-14. PubMed ID: 25853383
[TBL] [Abstract][Full Text] [Related]
11. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of pelvic exenteration for gynecologic malignancies.
Moolenaar LR; van Rangelrooij LE; van Poelgeest MIE; van Beurden M; van Driel WJ; van Lonkhuijzen LRCW; Mom CH; Zaal A
Gynecol Oncol; 2023 Apr; 171():114-120. PubMed ID: 36870097
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in pelvic exenteration for gynecological malignancies.
Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
[TBL] [Abstract][Full Text] [Related]
14. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.
Donati OF; Lakhman Y; Sala E; Burger IA; Vargas HA; Goldman DA; Andikyan V; Park KJ; Chi DS; Hricak H
Eur Radiol; 2013 Oct; 23(10):2906-15. PubMed ID: 23652852
[TBL] [Abstract][Full Text] [Related]
15. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
[TBL] [Abstract][Full Text] [Related]
16. The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration.
Burger IA; Vargas HA; Donati OF; Andikyan V; Sala E; Gonen M; Goldman DA; Chi DS; Schöder H; Hricak H
Gynecol Oncol; 2013 Jun; 129(3):586-592. PubMed ID: 23369941
[TBL] [Abstract][Full Text] [Related]
17. Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.
Mourton SM; Chi DS; Sonoda Y; Alektiar KM; Venkatraman ES; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2006 Mar; 100(3):533-6. PubMed ID: 16226800
[TBL] [Abstract][Full Text] [Related]
18. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
[TBL] [Abstract][Full Text] [Related]
19. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies.
Andikyan V; Khoury-Collado F; Sandadi S; Tew WP; O'Cearbhaill RE; Konner JA; Sonoda Y; Barakat RR; Chi DS; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Jun; 23(5):923-8. PubMed ID: 23698798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
